Prenara is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sterling-knight Pharmaceuticals, Llc. The primary component is Vitamin A; Ascorbic Acid; Vitamin D; Thiamine; Riboflavin; Niacinamide; Pyridoxine Hydrochloride; Folic Acid; Cyanocobalamin; Calcium; Iodine; Copper; Magnesium; Zinc.
Product ID | 69336-352_f6d38c4c-309f-4a20-8e7b-126bfed0feb9 |
NDC | 69336-352 |
Product Type | Human Prescription Drug |
Proprietary Name | Prenara |
Generic Name | Prenara |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2020-03-09 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | Sterling-Knight Pharmaceuticals, LLC |
Substance Name | VITAMIN A; ASCORBIC ACID; VITAMIN D; THIAMINE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBALAMIN; CALCIUM; IODINE; COPPER; MAGNESIUM; ZINC |
Active Ingredient Strength | 1000 [iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 |
Pharm Classes | Vitamin A [CS],Vitamin A [EPC],Vitamin C [EPC],Ascorbic Acid [CS],Vitamin D [CS],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Calcium [CS],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Copper [CS],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-03-09 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-03-09 |
Ingredient | Strength |
---|---|
VITAMIN A | 1000 [iU]/1 |
SPL SET ID: | bb306403-27d2-452b-bc91-fbf033d22d10 |
Manufacturer | |
UNII |